Author

Bellentani S

17 декабря 2019 г.
Бремя неалкогольной жировой болезни печени - Швейцария, 2018-2030 гг.
Summary As a result of epidemic levels of obesity and diabetes mellitus, nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH) will contribute to increases in the liver-related disease burden in Switzerland. A Markov model was built to quantify fibrosis progression among the NAFLD and NASH populations, and predict disease burden up to 2030. Long-term […]

Читать далее
8 июля 2018 г.
Моделирование бремени НАЖБП в Китае, Франции, Германии, Италии, Японии, Испании, Великобритании и США на период 2016–2030 гг.
Summary Background & Aims Non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH) are increasingly a cause of cirrhosis and hepatocellular carcinoma globally. This burden is expected to increase as epidemics of obesity, diabetes and metabolic syndrome continue to grow. The goal of this analysis was to use a Markov model to forecast NAFLD disease […]

Читать далее